Future longitudinal studies are required to understand the mechanisms through which the upregulation of OGN influences the risk of impaired kidney function in T2D patients and to confirm the potential usefulness of serum OGN as a potential biomarker of kidney status in clinical settings to establish preventive and therapeutic approaches in the T2D population. Here, OGN is linked to type 2 diabetes mellitus.